The Safest in Personalized and Predictive Insulin Dosing
Monarch Medical Technologies, the maker of the EndoTool® Glucose Management System, is the leading provider of precision insulin dosing technology for improved patient outcomes.
A True Precision Medicine Tool for Inpatient Glucose Management
Proven, patented algorithms to model, predict and adapt dosing recommendations to each patient and their individual response for more precise, safer inpatient insulin therapy.
Intravenous (IV) insulin dosing software to manage hyperglycemia while avoiding hypoglycemia
Basal-bolus subcutaneous insulin dosing software supporting industry guidelines and standards
Clinical Research & Case Studies
Demonstrated to Improve the Quality and Safety of Glucose Management
Learn MoreSpotlight
Check out the latest news and resources from the Monarch team and EndoTool users.
Complimentary Webinar
It’s About Time! Reducing Hypoglycemia in the Inpatient Setting
Register to attend our November 21st webinar discussing the common causes for inpatient hypoglycemia, including the timing of blood glucose checks and insulin delivery, and initiatives that can be taken to reduce hypoglycemia.
Register for the WebinarArticle
Patrick Burgess, MD: Hypoglycemia and Impact of Late Glucose Checks
Patrick Burgess, MD, PhD, inventor of EndoTool, sat down with MD Magazine to discuss his study on the impact of late blood glucose checks as well as other important topics being covered at the American Diabetes Association's 79th Scientific Sessions.
Read MoreClinical Research
Use of a Computer-Guided Glucose Management System to Improve Glycemic Control and Address National Quality Measures
A retrospective observational study evaluated the 7-year impact of the EndoTool® eGMS in intensive and intermediate units at Vidant Medical Center, a 900-bed tertiary teaching hospital.
Read More